211 related articles for article (PubMed ID: 19184104)
1. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
3. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
4. Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
Kim YD; Hwang S; Lee YJ; Kim KH; Ahn CS; Park KM; Moon DB; Ha TY; Song GW; Jung DH; Park SR; Hong HN; Lee SG
Hepatogastroenterology; 2012; 59(117):1512-5. PubMed ID: 22683968
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
Wong IH; Yeo W; Leung T; Lau WY; Johnson PJ
Cancer Lett; 2001 Jun; 167(2):183-91. PubMed ID: 11369140
[TBL] [Abstract][Full Text] [Related]
7. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
Yan D; He Q; Chen Y; Wang L; Zhang X
J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
[TBL] [Abstract][Full Text] [Related]
8. Combined detection of mRNA expression of Alpha-fetoprotein in peripheral blood and telomerase activity of monocytes in hepatocellular carcinoma patients.
Huang YK; Fan XG; Qiu F; Wang ZM
Hepatogastroenterology; 2013; 60(121):1-5. PubMed ID: 22773301
[TBL] [Abstract][Full Text] [Related]
9. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma.
Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K
J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615
[TBL] [Abstract][Full Text] [Related]
10. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
11. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
12. Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction.
Yang YJ; Chen H; Huang P; Li CH; Dong ZH; Hou YL
Clin Invest Med; 2011 Aug; 34(4):E238. PubMed ID: 21810382
[TBL] [Abstract][Full Text] [Related]
13. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y
Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949
[TBL] [Abstract][Full Text] [Related]
14. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Miura N; Shiota G; Nakagawa T; Maeda Y; Sano A; Marumoto A; Kishimoto Y; Murawaki Y; Hasegawa J
Oncology; 2003; 64(4):430-4. PubMed ID: 12759542
[TBL] [Abstract][Full Text] [Related]
15. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
[TBL] [Abstract][Full Text] [Related]
17. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M
J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174
[TBL] [Abstract][Full Text] [Related]
19. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
20. A novel biomarker TERTmRNA is applicable for early detection of hepatoma.
Miura N; Osaki Y; Nagashima M; Kohno M; Yorozu K; Shomori K; Kanbe T; Oyama K; Kishimoto Y; Maruyama S; Noma E; Horie Y; Kudo M; Sakaguchi S; Hirooka Y; Ito H; Kawasaki H; Hasegawa J; Shiota G
BMC Gastroenterol; 2010 May; 10():46. PubMed ID: 20482774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
